Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes Mellitus
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes Mellitus ; day:5 ; month:5 ; year:2020 ; pages:1-22
Advances in therapy ; (5.5.2020), 1-22
- Creator
-
Kinduryte Schorling, Ona
Clark, Douglas
Zwiener, Isabella
Kaspers, Stefan
Lee, Jisoo
Iliev, Hristo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-020-01329-7
- URN
-
urn:nbn:de:101:1-2020071222050790354661
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kinduryte Schorling, Ona
- Clark, Douglas
- Zwiener, Isabella
- Kaspers, Stefan
- Lee, Jisoo
- Iliev, Hristo
- SpringerLink (Online service)
Other Objects (12)
Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I–III Clinical Trials
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus
Safety and Tolerability of Combinations of Empagliflozin and Linagliptin in Patients with Type 2 Diabetes: Pooled Data from Two Randomized Controlled Trials
Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis
Population Pharmacokinetics and Exposure–Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes
Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies
Stress echocardiography: safety and tolerability
The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis
Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Empagliflozin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A16-12
Empagliflozin/Metformin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A16-13
Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I–III Clinical Trials
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus
Safety and Tolerability of Combinations of Empagliflozin and Linagliptin in Patients with Type 2 Diabetes: Pooled Data from Two Randomized Controlled Trials
Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis
Population Pharmacokinetics and Exposure–Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes
Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies
Stress echocardiography: safety and tolerability
The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis
Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Empagliflozin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A16-12
Empagliflozin/Metformin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A16-13
Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I–III Clinical Trials
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus
Safety and Tolerability of Combinations of Empagliflozin and Linagliptin in Patients with Type 2 Diabetes: Pooled Data from Two Randomized Controlled Trials
Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis
Population Pharmacokinetics and Exposure–Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes
Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies
Stress echocardiography: safety and tolerability
The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis
Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Empagliflozin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A16-12